<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">miR-184 Inhibits Tumor Invasion, Migration and Metastasis in Nasopharyngeal Carcinoma by Targeting Notch2</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
				<date type="published" when="2018-09-13">13 September, 2018</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><forename type="first">Hong-Ming</forename><surname>Zhu</surname></persName>
							<affiliation key="aff1">
								<orgName type="institution" key="instit1">Jiangsu Cancer Hospital</orgName>
								<orgName type="institution" key="instit2">Jiangsu Institue of Cancer Research</orgName>
								<orgName type="institution" key="instit3">Nanjing Medical University Affiliated Cancer Hospital</orgName>
								<address>
									<settlement>Nanjing</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Xue-Song</forename><surname>Jiang</surname></persName>
							<affiliation key="aff1">
								<orgName type="institution" key="instit1">Jiangsu Cancer Hospital</orgName>
								<orgName type="institution" key="instit2">Jiangsu Institue of Cancer Research</orgName>
								<orgName type="institution" key="instit3">Nanjing Medical University Affiliated Cancer Hospital</orgName>
								<address>
									<settlement>Nanjing</settlement>
								</address>
							</affiliation>
							<affiliation key="aff2">
								<orgName type="institution">The Fourth Clinical School of Nanjing Medical University</orgName>
								<address>
									<settlement>Nanjing</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Hui-Zi</forename><surname>Li</surname></persName>
							<affiliation key="aff2">
								<orgName type="institution">The Fourth Clinical School of Nanjing Medical University</orgName>
								<address>
									<settlement>Nanjing</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Lu-Xi</forename><surname>Qian</surname></persName>
							<affiliation key="aff1">
								<orgName type="institution" key="instit1">Jiangsu Cancer Hospital</orgName>
								<orgName type="institution" key="instit2">Jiangsu Institue of Cancer Research</orgName>
								<orgName type="institution" key="instit3">Nanjing Medical University Affiliated Cancer Hospital</orgName>
								<address>
									<settlement>Nanjing</settlement>
								</address>
							</affiliation>
							<affiliation key="aff2">
								<orgName type="institution">The Fourth Clinical School of Nanjing Medical University</orgName>
								<address>
									<settlement>Nanjing</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Ming-Yu</forename><surname>Du</surname></persName>
							<affiliation key="aff1">
								<orgName type="institution" key="instit1">Jiangsu Cancer Hospital</orgName>
								<orgName type="institution" key="instit2">Jiangsu Institue of Cancer Research</orgName>
								<orgName type="institution" key="instit3">Nanjing Medical University Affiliated Cancer Hospital</orgName>
								<address>
									<settlement>Nanjing</settlement>
								</address>
							</affiliation>
							<affiliation key="aff3">
								<orgName type="institution">Xuzhou Medical University</orgName>
								<address>
									<settlement>Xuzhou</settlement>
									<country key="CN">China</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Zhi-Wei</forename><surname>Lu</surname></persName>
							<affiliation key="aff2">
								<orgName type="institution">The Fourth Clinical School of Nanjing Medical University</orgName>
								<address>
									<settlement>Nanjing</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Jing</forename><surname>Wu</surname></persName>
							<affiliation key="aff1">
								<orgName type="institution" key="instit1">Jiangsu Cancer Hospital</orgName>
								<orgName type="institution" key="instit2">Jiangsu Institue of Cancer Research</orgName>
								<orgName type="institution" key="instit3">Nanjing Medical University Affiliated Cancer Hospital</orgName>
								<address>
									<settlement>Nanjing</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Xiao-Kang</forename><surname>Tian</surname></persName>
							<affiliation key="aff1">
								<orgName type="institution" key="instit1">Jiangsu Cancer Hospital</orgName>
								<orgName type="institution" key="instit2">Jiangsu Institue of Cancer Research</orgName>
								<orgName type="institution" key="instit3">Nanjing Medical University Affiliated Cancer Hospital</orgName>
								<address>
									<settlement>Nanjing</settlement>
								</address>
							</affiliation>
							<affiliation key="aff3">
								<orgName type="institution">Xuzhou Medical University</orgName>
								<address>
									<settlement>Xuzhou</settlement>
									<country key="CN">China</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Qian</forename><surname>Fei</surname></persName>
							<affiliation key="aff1">
								<orgName type="institution" key="instit1">Jiangsu Cancer Hospital</orgName>
								<orgName type="institution" key="instit2">Jiangsu Institue of Cancer Research</orgName>
								<orgName type="institution" key="instit3">Nanjing Medical University Affiliated Cancer Hospital</orgName>
								<address>
									<settlement>Nanjing</settlement>
								</address>
							</affiliation>
							<affiliation key="aff2">
								<orgName type="institution">The Fourth Clinical School of Nanjing Medical University</orgName>
								<address>
									<settlement>Nanjing</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Xia</forename><surname>He</surname></persName>
							<affiliation key="aff1">
								<orgName type="institution" key="instit1">Jiangsu Cancer Hospital</orgName>
								<orgName type="institution" key="instit2">Jiangsu Institue of Cancer Research</orgName>
								<orgName type="institution" key="instit3">Nanjing Medical University Affiliated Cancer Hospital</orgName>
								<address>
									<settlement>Nanjing</settlement>
								</address>
							</affiliation>
							<affiliation key="aff2">
								<orgName type="institution">The Fourth Clinical School of Nanjing Medical University</orgName>
								<address>
									<settlement>Nanjing</settlement>
								</address>
							</affiliation>
							<affiliation key="aff3">
								<orgName type="institution">Xuzhou Medical University</orgName>
								<address>
									<settlement>Xuzhou</settlement>
									<country key="CN">China</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Li</forename><surname>Yin</surname></persName>
							<affiliation key="aff1">
								<orgName type="institution" key="instit1">Jiangsu Cancer Hospital</orgName>
								<orgName type="institution" key="instit2">Jiangsu Institue of Cancer Research</orgName>
								<orgName type="institution" key="instit3">Nanjing Medical University Affiliated Cancer Hospital</orgName>
								<address>
									<settlement>Nanjing</settlement>
								</address>
							</affiliation>
							<affiliation key="aff2">
								<orgName type="institution">The Fourth Clinical School of Nanjing Medical University</orgName>
								<address>
									<settlement>Nanjing</settlement>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="institution" key="instit1">Jiangsu Cancer Hospital</orgName>
								<orgName type="institution" key="instit2">Jiangsu Institue of Cancer Research</orgName>
								<orgName type="institution" key="instit3">Nanjing Medical University Affiliated Cancer Hospital</orgName>
								<address>
									<settlement>Nanjing</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff0">
								<orgName type="department">1564 Cellular Physiology and Biochemistry Cellular Physiology and Biochemistry</orgName>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff4">
								<orgName type="institution" key="instit1">Jiangsu Cancer Hospital</orgName>
								<orgName type="institution" key="instit2">Jiangsu Institue of Cancer Research</orgName>
								<orgName type="institution" key="instit3">Nanjing Medical University Affiliated Cancer Hospital</orgName>
								<address>
									<addrLine>42 Bai Zi Ting Road</addrLine>
									<postCode>210000</postCode>
									<settlement>Nanjing</settlement>
									<region>Jiangsu</region>
									<country key="CN">China</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff5">
								<orgName type="department">Cellular Physiology and Biochemistry Cellular Physiology and Biochemistry</orgName>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff6">
								<orgName type="department">Cellular Physiology and Biochemistry Cellular Physiology and Biochemistry</orgName>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff7">
								<orgName type="department">Cellular Physiology and Biochemistry Cellular Physiology and Biochemistry</orgName>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff8">
								<orgName type="department">Cellular Physiology and Biochemistry Cellular Physiology and Biochemistry</orgName>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff9">
								<orgName type="department">1574 Cellular Physiology and Biochemistry Cellular Physiology and Biochemistry</orgName>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff10">
								<orgName type="department">Cellular Physiology and Biochemistry Cellular Physiology and Biochemistry</orgName>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff11">
								<orgName type="department">Cellular Physiology and Biochemistry Cellular Physiology and Biochemistry</orgName>
							</affiliation>
						</author>
						<title level="a" type="main">miR-184 Inhibits Tumor Invasion, Migration and Metastasis in Nasopharyngeal Carcinoma by Targeting Notch2</title>
					</analytic>
					<monogr>
						<imprint>
							<date type="published" when="2018-09-13">13 September, 2018</date>
						</imprint>
					</monogr>
					<idno type="MD5">A14B6182D219A99EF308A166932BA5A7</idno>
					<idno type="DOI">10.1159/000493458</idno>
					<note type="submission">Accepted: 4 September</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.2-SNAPSHOT" ident="GROBID" when="2022-05-18T11:36+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>
					<term>miR-184</term>
					<term>Nasopharyngeal carcinoma</term>
					<term>Notch2</term>
					<term>Invasion</term>
					<term>Metastasis</term>
					<term>EMT miR-184 Inhibits Tumor Invasion miR-184 Inhibits Tumor Invasion miR-184 Inhibits Tumor Invasion</term>
				</keywords>
			</textClass>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>Background/Aims: A recent study found that dysregulated microRNA-184 (miR-184) is involved in the proliferation and survival of nasopharyngeal carcinoma (NPC).</s><s>This study aimed to evaluate the detailed mechanisms of invasion, migration and metastasis of NPC cells.</s><s>Methods: Quantitative reverse-transcription PCR (qRT-PCR) and Western blot were used to confirm the expression levels of miR-184 and Notch2.</s><s>NPC cell invasion and migration were subsequently examined using in vitro cell invasion and wound-healing assays, respectively.</s><s>MicroRNA (miRNA) target gene prediction databases and dual-luciferase reporter assay were adopted to validate the target genes of miR-184.</s><s>Results: MiR-184 was downregulated in the NPC cell lines.</s><s>The miR-184 inhibitor increased the number of invading NPC cells, whereas miR-184 mimics inhibited the invasive ability of such cells.</s><s>The protein level of E-cadherin decreased, whereas those of N-cadherin and vimentin increased in the anti-miR-184 group.</s><s>This result showed that miR-184 inhibited NPC cell invasion and metastasis by regulating EMT progression.</s><s>MiRNA target gene prediction databases indicated the potential of Notch2 as a direct target gene of miR-184.</s><s>Such a notion was then validated by results of dual-luciferase reporter assay.</s><s>Notably, shRNANotch2 restrained the EMT and partially abrogated the inhibitory effects of miR-184 on EMT progression in NPC cells.</s><s>Conclusion: MiR-184 functions as a tumour-suppressive miRNA targeting Notch2 and inhibits the invasion, migration and metastasis of NPC.</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Introduction</head><p><s>Nasopharyngeal carcinoma (NPC) is a common head and neck malignant tumour in the people of South China, particularly in Guangdong Province, Guangxi Province, Hunan Province, Fujian Province, Jiangxi Province, and Hong Kong Special Administrative Region <ref type="bibr" target="#b0">[1]</ref>.</s><s>Radiotherapy is a commonly used method for treating NPC and is combined with chemotherapy to improve patient survival rate <ref type="bibr" target="#b1">[2]</ref>.</s><s>However, NPC metastasis is an important cause of poor survival among patients with advanced NPC <ref type="bibr" target="#b2">[3]</ref>.</s><s>The underlying molecular mechanisms in NPC metastasis remain unclear.</s><s>Therefore, the molecular mechanisms of NPC invasion and metastasis must be urgently elucidated to improve the prognosis of patients with NPC.</s></p><p><s>MicroRNAs (miRNAs) are a class of endogenous short non-coding RNAs, which can repress gene expression by base pairing to specific recognition sequences in the 3′-untranslated region (UTR) of their target mRNAs <ref type="bibr" target="#b3">[4]</ref>.</s><s>Accumulating evidence has shown that miRNAs are associated with tumourigenesis, progression and metastasis either as oncogenes or tumour suppressors in NPC and other cancers by regulating target gene expression <ref type="bibr" target="#b4">[5]</ref><ref type="bibr" target="#b5">[6]</ref><ref type="bibr" target="#b6">[7]</ref>.</s><s>Several miRNAs have been reported to serve as oncogenes or suppressor genes in NPC cell migration, invasion and metastasis.</s><s>These miRNAs include miR-145 <ref type="bibr" target="#b7">[8]</ref>, miR-429 <ref type="bibr" target="#b8">[9]</ref>, miR-143 <ref type="bibr" target="#b9">[10]</ref> and miR-148-b <ref type="bibr" target="#b10">[11]</ref>.</s><s>These studies suggest that miRNAs play important roles in NPC and provide a novel area of study in NPC invasion and metastasis.</s></p><p><s>MiRNA-184 (miR-184) is an evolutionarily conserved non-coding RNA oligomer located in region 25.1 of the q-arm of chromosome 15.</s><s>Mature miR-184, which contains 22 nucleotides, exhibits expression patterns specific to tissue and developmental stages <ref type="bibr" target="#b11">[12]</ref>.</s><s>It has been extensively reported that miR-184 activity participates in the control of a wide range of biological functions and processes such as changes in response to DOR activation in the Rat Liver Under Prolonged Hypoxia <ref type="bibr" target="#b12">[13]</ref>.</s><s>MiR-184 has been extensively explored in various cancers.</s><s>Decreased miR-184 expression levels were noted in gliomal cells <ref type="bibr" target="#b13">[14,</ref><ref type="bibr" target="#b14">15]</ref>, central nervous system lymphoma cells <ref type="bibr" target="#b15">[16]</ref> and renal cell carcinoma <ref type="bibr" target="#b16">[17]</ref>.</s><s>By contrast, miR-184 expression was found to be upregulated in pancreatic ductal adenocarcinoma <ref type="bibr" target="#b17">[18]</ref>, hepatocellular carcinoma <ref type="bibr" target="#b18">[19]</ref> and tongue squamous cell carcinoma <ref type="bibr" target="#b19">[20]</ref>.</s><s>In a previous study, dysregulated miR-184 contributed to growth and apoptosis <ref type="bibr" target="#b20">[21]</ref>.</s><s>However, the role of miR-184 in NPC invasion and metastasis remains unclear; thus, it was investigated in this study.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Materials and Methods</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Cell lines and Cell culture</head><p><s>Six NPC cell lines (5-8F, 6-10B, HNE1, SUNE1, CNE-1, and CNE-2) were cultured in RPMI-1640 (Hyclone, Logan, UT, USA ) and immortalized nasopharyngeal epithelial cell NP69 supplemented with 5% FBS (Gibco BRL, Gaithersburg, MD, USA ) in a humidified atmosphere of 5% CO2 at 37°C.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Cell transfection</head><p><s>hsa-miR-184 mimic/inhibitor and hsa-miR-184 mimic/inhibitor negative control (NC) were synthesized by RiboBio (Guangzhou, China).</s><s>Notch2-siRNA and NC siRNA were obtained from RiboBio (Guangzhou, China).</s><s>CNE-1 and CNE-2 cells were plated in six-well plates (1.5×10 5 cells per well) for 24h and transfected with miR-184 mimic/inhibitor/Notch2-siRNA using Lipofectamine 2000 (Invitrogen, Carlsbad, CA) according to the manufacturer's protocol.</s><s>Cells transfected with miRNA or siRNA were harvested 48 h post-transfection.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Quantitative real-time PCR assays</head><p><s>Total RNA was purified using TRIzol reagent (Invitrogen,Carlsbad, CA) according to the manufacturer's instructions to detect mRNA expression.</s><s>Then, 2 µg of total RNA was reverse-transcribed using Moloney murine leukemia virus reverse transcriptase (Promega, Madison, WI, USA) according to manufacturer's instructions.</s><s>qRT-PCR was performed using an ABI 7300 FAST Real-Time PCR System (Applied Biosystems, Carlsbad, CA, USA) and a SYBR Green PCR Kit (Takara, Dalian,China).</s><s>The relative expression level of miRNA or mRNA was quantified with the 2 -ΔΔCt method after normalization with the endogenous reference U6 small nuclear RNA or β-actin , respectively.</s><s>The expression of Notch2 and β-actin was examined using the following specific primers: 5'-CAAGGAACCTGCTTTGATGACA-3'and 5'-GGGGAACAGGGAGCCAATAC-3 and 5'-GGACTTCGAGCAAGAGATGG-3' and 5'-AGCACTGTGTTGGCGTACAG-3', respectively.</s><s>All reactions were performed in triplicate for each sample.</s><s>Fold changes for miR-184 and Notch2 expression levels were calculated using the 2 -ΔΔCt method.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Transwell invasion and migration assay</head><p><s>Cell invasion was conducted using Matrigel invasion assay (BD Biosciences) according to the manufacturer's protocols.</s><s>Transfected CNE-1 and CNE-2 cells were cultured for 48 h.</s><s>The cells were then harvested, resuspended (5×104 cells per well) in 200μl of serum-free media, and placed in the upper compartment of a chamber (Corning, NY, USA).</s><s>The lower compartment was filled with 500μl of RPMI-1640 and 20% FBS.</s><s>After 24h of incubation, cells that invaded through the Matrigel membrane were fixed with 4% paraformaldehyde and stained with crystal violet.Six random fields of cells were counted in each well under a microscope at a magnification of ×100.</s><s>Three independent experiments were conducted.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Wound-healing migration assay</head><p><s>Cells were cultured in six-well plates (1.5×105 cells per well) and transfected with miRNA or siRNA.</s><s>When the cells reached 90% confluence, a single wound was created in the center of the cell monolayer by using a T-200-Y pipet tip.</s><s>Wound areas were visualized under an optical microscope with a magnification of×100.</s><s>Cell migration capability was expressed by gap closure.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Dual-luciferase reporter assay</head><p><s>Luciferase reporter assay was performed as described previously <ref type="bibr" target="#b21">[22]</ref>.</s><s>The NPC cell line CNE-1(1.5×10 9</s><s>cells per six-well plate) was co-transfected with miR-184 mimic or negative control; PGL3-Notch2 3′UTR wild-type vector or PGL3-Notch2 3′UTR mutant (mut) vector containing firefly luciferase reporter; and 3′UTR of the Notch2 gene (Promega, Madison, WI) using the transfection reagent Lipofectamine 2000 (Invitrogen, Carlsbad, CA).</s><s>Cells were harvested 48h after transfection.</s><s>Luciferase activities were analyzed using the Dual-Luciferase Reporter Assay System (Promega) according to the manufacturer's protocol.</s><s>Each experiment was done in triplicate.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Western blot analysis</head><p><s>After 48 h of transfection, cells were extracted and prepared in modified RIPA buffer (Beyotime, Shanghai, China).</s><s>Total protein was extracted, and protein concentration was quantified using a BCA protein assay kit (Beyotime, Shanghai, China).</s><s>A total of 20 mg of protein from each sample was used for Western blot analysis.The primary antibodies used in this study included monoclonal anti-Notch2 (1:1000; Abcam, HK), anti-E-cadherin (1:1000; Cell Signaling Technology,USA), anti-N-cadherin (1:1000; Cell Signaling Technology,USA), anti-Vimentin (1:1000; Cell Signaling Technology,USA), and anti-β-actin (1:2000; Cell Signaling Technology, USA) was used as the loading control.</s><s>Immunoreactive bands were visualized using ECL detection reagent (Millipore, Billerica, MA, USA).</s><s>All data analyses were repeated three times independently.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Tumour xenograft model</head><p><s>A new experimental model of spontaneous lymph node metastasis was developed for the present study as previously described <ref type="bibr" target="#b22">[23]</ref>.</s><s>Athymic male BALB/c nude mice aged 6-8 weeks were obtained from the Medical Centre of Yangzhou University (Yangzhou, China).</s><s>Spontaneous lymph node metastasis was then induced by injecting 2×10 6 CNE1 cells into the footpad of individual nude mice.</s><s>When the xenograft volumes reached 60 mm 3 , all the nude mice were divided into five groups (n = 5 mice each) as follows: negative control group (CNE1/saline buffer) as the G1 group, control agomir group (CNE1/control agomir group) as the G2 group, miR-184 agomir group (CNE1/miR-184 agomir group) as the G3 group, control antagomir group (CNE1/control antagomir group) as the G4 group and miR-184 antagomir group (CNE1/miR-184 antagomir group) as the G5 group.</s><s>Subsequently, 5 nmol miR-184 agomir or control agomir (RiboBio) in 20 μl of saline buffer was injected subcutaneously into the footpad to the tumour mass of each mouse in the G3 or G2 group.</s><s>Meanwhile, 10 nmol miR-184 antagomir or control antagomir (RiboBio) in 20 μl of saline buffer was injected subcutaneously into the footpad to the tumour mass of each mouse in the G5 or G4 group.</s><s>Finally, 20 μl of saline buffer was injected subcutaneously into the footpad to the tumour mass of each mouse in the G1 group.</s><s>All groups were injected twice a week, and the tumour volume (in mm 3 )  was measured by a calliper every 3-4 days and calculated using the modified ellipse formula (volume = length×width 2 /2).</s><s>The experiment was terminated when the control primary tumour invaded the popliteal region or the mouse died.</s><s>At 44 days after injection, the mice were killed, and tumours were weighed after necropsy.</s><s>The presence of popliteal lymph node metastasis was observed by necropsy.</s><s>Animal experiments were approved by the Animal Committee of Nanjing Origin Biosciences, China.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Immunohistochemistry</head><p><s>At the end of the study, all mice were sacrificed, and the tumors were surgically excised.</s><s>Parts of the tumour tissues were fixed in 10% buffered formalin and embedded in paraffin.</s><s>Hematoxylin and eosin staining was performed on the 6 μm-thick paraffin-embedded tumour sections for histological study.</s><s>For immunohistochemistry, sections were incubated with primary antibodies against E-cadherin, N-cadherin and vimentin (Cell Signalling Technology, USA) overnight at 4 °C after permeabilisation with a solution of 0.1% sodium citrate and 0.1% Triton X-100 and blocking with 10% rabbit serum.</s><s>The slides were washed with PBS and then incubated with secondary antibody labelled with horseradish peroxidase at room temperature for 2 h.</s><s>After colour development by diaminobenzidine (Maixin Bio-Tech Co., Ltd), the slices were counterstained in hematoxylin and mounted with a neutral resin medium.</s><s>The whole slide was first viewed at 100× magnification to identify a 'hot spot' representing the area of highest vessel density.</s><s>The field was then switched to 400× magnification for analysis.</s><s>For each slide, the epithelial-mesenchymal transition (EMT) was calculated as the average number of E-cadherin(+), N-cadherin(+) and vimentin(+) cells in eight visual fields.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Statistical analysis</head><p><s>Statistical analyses were performed through Student's t-test and one-way ANOVA with GraphPad Prism 7.0 software and SPSS 13.0.</s><s>Data are expressed as the mean±standard deviation from at least three separate experiments.</s><s>Differences were considered significant at P&lt;0.05.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Results</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>MiR-184 is downregulated and Notch2 is upregulated in NPC cell lines</head><p><s>To confirm the correlation between NPC tumourigenesis and miRNA gene expression, we performed quantitative reverse-transcription PCR (qRT-PCR) to determine the mRNA level of miR-184 in six NPC cell lines (5-8F, 6-10B, HNE1, SUNE1, CNE-1 and CNE-2) and NP69.</s><s>MiR-184 expression levels were higher in NP69 than in the six NPC cell lines (Fig. <ref type="figure" target="#fig_1">1A</ref>).</s><s>By contrast, NP69 expressed the lowest amounts of the Notch2 mRNA and protein than the NPC cell lines (Fig. <ref type="figure" target="#fig_1">1B and 1C</ref>).</s><s>The results indicated that miR-184 was significantly downregulated and Notch2 is upregulated in NPC cell lines.</s><s>Thus, miR-184 may be a tumor suppressor in NPC and may have a negative correlation with Notch2.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>MiR-184 overexpression inhibits invasion and migration in the NPC cell lines</head><p><s>To examine whether miR-184 affects the migration and invasion of NPC cells, we performed cell wound-healing assay and Transwell experimental assays.</s><s>MiR-184 mimic or NC was transfected into CNE-1 and CNE-2 cells.</s><s>Following transfection, qRT-PCR was performed to detect miR-184 expression.</s><s>qRT-PCR analysis results showed that the CNE-1 and CNE-2 cells were transfected with miR-184 mimics, which significantly increased miR-184 expression (Fig. <ref type="figure" target="#fig_2">2A</ref>).</s><s>Forcing miR-184 expression distinctly inhibited CNE-1 and CNE-2 cell migration and invasion relative to those in the control group (Fig. <ref type="figure" target="#fig_2">2B and 2C</ref>).</s><s>In the wound-healing assay, CNE-1 and CNE-2 cell migration was inhibited relative to that in the negative control group by miR-184 mimic transfection (Fig. <ref type="figure" target="#fig_2">2D</ref>).</s><s>MiR-184 overexpression obviously suppressed NPC cell migration and invasion, and these results suggest that miR-184 expression exerted an anti-metastatic effect.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>MiR-184 inhibition increases invasion and migration in NPC cells</head><p><s>To further determine the effect of miR-184 silencing on NPC's cell migration and invasive abilities, we also transiently transfected CNE-1 and CNE-2 cells with miR-184 inhibitor or a control and then performed wound-healing assays, Transwell migration assays and</s></p><note type="other">Cellular Physiology and Biochemistry Cellular Physiology and Biochemistry</note><p><s>invasion assays.</s><s>MiR-184 inhibitor expression gradually decreased in the CNE-1 and CNE-2 cell lines (Fig. <ref type="figure" target="#fig_2">2A</ref>).</s><s>As expected, Transwell assay confirmed that the downregulated expression of miR-184 in CNE-1 and CNE-2 cells remarkably enhanced NPC cell migration and invasion relative to that in the control cells (Fig. <ref type="figure" target="#fig_6">3A and 3B</ref>).</s><s>Similarly, in the wound-healing assay, cell migration was significantly higher in the cells transfected with the miR-184 inhibitor than in the negative control group (Fig. <ref type="figure" target="#fig_6">3C</ref>).</s></p><p><s>These results indicate that miR-184 silencing could promote NPC cell migration and invasion in vitro.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>MiR-184 inhibits EMT</head><p><s>EMT is a key event in cancer invasion and metastasis; hence, we examined whether miR-184 can induce EMT in NPCs.</s><s>We analysed the effect of miR-184 on EMT by detecting the protein levels of EMT markers.</s><s>Results showed that miR-184 increased the expression of epithelial marker E-cadherin and decreased the expression of N-cadherin and vimentin (Fig. <ref type="figure" target="#fig_4">4</ref>).</s><s>Meanwhile, after miR-184 inhibition, the protein E-cadherin level was reduced, whereas the N-cadherin and vimentin levels were raised (Fig. <ref type="figure" target="#fig_4">4</ref>).</s><s>These findings indicate that miR-184 could suppress EMT.</s></p><note type="other">Cellular Physiology and Biochemistry Cellular Physiology and Biochemistry</note></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Notch2 is a direct target of miR-184 in NPC</head><p><s>To investigate the target gene of miR-184 in NPC carcinogenesis, we used three public databases (miRwalk, miRanda and Targetscan) to predict the potential target gene of miR-184.</s><s>We found that Notch2 contained miR-184-binding sequences in its 3′-UTR regions (Fig. <ref type="figure" target="#fig_8">5A</ref>).</s><s>To verify whether miR-184 can repress the expression of Notch2 by directly interacting with the predicted binding site, we constructed luciferase reporter vectors that included wild-type (WT) and mutated Notch2 3′-UTR reporters.</s><s>We then co-transfected these reporters with miR-184 mimic and mimic control into CNE1 cells.</s><s>Luciferase assays showed that miR-184 significantly inhibited luciferase activity of the WT Notch2-3′-UTR reporter gene, whereas the activity of the mutant reporter gene was unaffected (Fig. <ref type="figure" target="#fig_8">5B</ref>).</s><s>To further confirm that Notch2 acts as a miR-184 target, we analysed the Notch2 mRNA and protein expression levels in the CNE-1 and CNE-2 cells transfected with miR-184 mimic or inhibitor by qRT-PCR and Western blot.</s><s>Notch2 expression simultaneously decreased at the mRNA and protein levels after miR-184 overexpression (Fig. <ref type="figure" target="#fig_8">5C  and 5D</ref>).</s><s>Reciprocally, miR-184 knockdown was accompanied with augmented Notch2 expression in the CNE1 cells (Fig. <ref type="figure" target="#fig_8">5C and 5E</ref>).</s><s>These results indicate that Notch2 was directly and negatively regulated by miR-184.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Notch2 promotes EMT in NPC</head><p><s>Notch2 has been found to be involved in cell migration and invasion.</s><s>A previous study showed that Notch2 knockdown can suppresses gliomal cell invasion <ref type="bibr" target="#b23">[24]</ref>.</s><s>Recent investigations have indicated that Notch2 promotes EMT in oesophageal squamous cell cancer <ref type="bibr" target="#b24">[25]</ref>.</s><s>To further prove whether Notch2 is associated with NPC cell migration and invasion, we transiently transfected CNE-1 and CNE-2 cells with Notch2-small interference RNA (siRNA) or NC-siRNA and conducted wound-healing assays, Transwell assays and Western blot to examine the effect of Notch2 on    the EMT process.</s><s>After transfection, the mRNA expression of Notch2 obviously decreased as confirmed by qRT-PCR (Fig. <ref type="figure" target="#fig_10">6A</ref>).</s><s>The downregulation of Notch2 significantly decreased the migration and invasion ability of CNE-1 and CNE-2 cells (Fig. <ref type="figure" target="#fig_10">6B  and 6C</ref>).</s><s>As expected, Notch2 silencing inhibited the woundclosing activities of the CNE-1 and CNE-2 cells compared with those in the controls (Fig. <ref type="figure" target="#fig_10">6D</ref>).</s><s>Western blot revealed that the expression levels of N-cadherin and vimentin were diminished, whereas that of E-cadherin was raised, in the anti-Notch2 group (Fig. <ref type="figure" target="#fig_10">6E</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>MiR-184 inhibits EMT by suppressing Notch2</head><p><s>To evaluate the molecular mechanism by which miR-184 inhibits invasion and metastasis in NPC cells, we assembled four groups for analysis.</s><s>These groups were miR-184-NC with Notch2-NC, anti-miR-184 with si-Notch2, anti-miR-184 with Notch2-NC and miR-184-NC with si-Notch2.</s><s>The miR-184 inhibitor increased the invasion and migration abilities of NPC cells, whereas shRNA-Notch2 abolished this change (Fig. <ref type="figure" target="#fig_11">7A and 7B</ref>).</s><s>We then examined the expression of the epithelial marker E-cadherin and mesenchymal markers vimentin and N-cadherin by Western blot.</s><s>The miR-184 inhibitor reduced the EMT-related protein E-cadherin levels and increased the N-cadherin and vimentin levels in the CNE-1 and CNE-2 cells.</s><s>However, co-transfection with shRNA-Notch2 partially abolished these alterations at the protein level (Fig. <ref type="figure" target="#fig_11">7C</ref>).</s><s>These results suggest that miR-184 inhibited EMT by suppressing Notch2 expression.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>MiR-184 inhibits NPC metastasis by decreasing EMT in vivo</head><p><s>To further investigate the effect of miR-184 on NPC metastasis in vivo, CNE-1 cell (2×10 6 cells) were injected into the footpad of nude mice.</s><s>When the xenograft volumes reached 60 mm 3 , corresponding reagents were subcutaneously injected into the footpad to the tumour mass of every mouse in each group.</s><s>Upon autopsy after 44 days, the tumour was removed and weighed, and tumour popliteal lymph node metastasis progression was observed.</s><s>Results showed that miR-184 overexpression significantly reduced the primary tumour size relative to that in the agomir-NC and negative control, and miR-184 inhibition evidently increased the tumour sizes relative to those in the antagomir-NC and negative control (Fig. <ref type="figure" target="#fig_13">8A and 8B</ref>).</s><s>Similarly, the tumour weight and mean volume demonstrated the same results with size (Fig. <ref type="figure" target="#fig_13">8C and 8D</ref>).</s><s>We then studied the effect of miR-184 on tumour metastasis in vivo.</s><s>Exogenous miR-184 suppressed the cell invasion and migration of NPC cells in vitro; thus, we reasoned that miR-184 may also inhibit metastasis in vivo.</s><s>Indeed, miR-184 obviously inhibited tumour popliteal lymph node metastasis (Fig. <ref type="figure" target="#fig_13">8A, 8B and 8E</ref>).</s><s>Immunohistochemistry assays also showed that endogenous miR-184 caused similar changes in the EMT markers in vivo (Fig. <ref type="figure" target="#fig_15">9A, B, C, D and E</ref>).</s><s>Collectively, the data suggest that miR-184 inhibited distal metastases in vivo.</s><s>Accumulating evidence has shown that miR-184 expression is dysregulated in human cancers types.</s><s>Such expression was found to be downregulated in glioma, and ectopic miR-184 expression suppressed the proliferation and invasion of gliomal cells by directly regulating SND1 <ref type="bibr" target="#b13">[14]</ref>.</s><s>In human colorectal cancer, miR-184 was downregulated in CRC tissues and cell lines, which significantly inhibited proliferation, migration and invasion in human colorectal cancer by directly targeting IGF-1R <ref type="bibr" target="#b25">[26]</ref>.</s><s>However, some studies have suggested miR-184 as a potential onco-miR in various human tumours.</s><s>Dysregulated miR-184 has been reported as a potential oncomir, which contributes to cell proliferation and cell apoptosis inhibition in tongue carcinoma <ref type="bibr" target="#b19">[20]</ref>.</s><s>Moreover, previous studies indicated that miRNA-184 acts as an oncogenic regulator by targeting INPPL1 in HCC development <ref type="bibr" target="#b26">[27]</ref>.</s><s>We</s></p><note type="other">Cellular Physiology and Biochemistry Cellular Physiology and Biochemistry</note><p><s>observed a difference between one normal sample and 6 NPC cell lines suggesting that miR-184 could be downregulated in NPC cell lines.</s><s>Upregulation and downregulation without other indications could be interpreted as differences between two populations.</s><s>Collectively, these studies demonstrated the possible role of miR-184 in regulating cancer carcinogenesis and progression.</s></p><p><s>In previous studies, miR-184, identified as a potential tumour suppressor, inhibited cell growth by modulating the C-MYC-controlled cell cycle transition and BCL2-repressed mitochondrial apoptosis in NPC <ref type="bibr" target="#b20">[21]</ref>.</s><s>In our work, we further investigated the mechanisms of miR-184 in NPC invasion and metastasis.</s><s>Results showed that miR-184 inhibited NPC invasion and metastasis through EMT inhibition by suppressing Notch2 expression.</s><s>Similarly, Notch2 knockdown exerted similar effects to those of miR-184 overexpression in NPC cells.</s></p><p><s>EMT is a critical process in promoting stationary tumour cells to migrate and invade.</s><s>Such a phenomenon is a developmental program that enables stationary epithelial cells to gain migratory and invasive abilities as single cells <ref type="bibr" target="#b27">[28]</ref>.</s><s>This progression can be triggered</s></p><note type="other">Cellular Physiology and Biochemistry Cellular Physiology and Biochemistry</note><p><s>by various developmental signalling pathways, such as tumour growth factor beta, Wnt, Notch, growth factor receptor tyrosine kinases and PLC-γ pathways <ref type="bibr" target="#b24">[25]</ref>.</s><s>Notch signalling is an evolutionarily conserved pathway involved in EMT and metastasis <ref type="bibr" target="#b28">[29]</ref><ref type="bibr" target="#b29">[30]</ref><ref type="bibr" target="#b30">[31]</ref><ref type="bibr" target="#b31">[32]</ref><ref type="bibr" target="#b32">[33]</ref>.</s><s>In mammals, Notch signalling includes four transmembrane Notch receptors (Notch-1, Notch-2, Notch-3 and Notch-4) and five canonical transmembrane ligands (Delta-like DLL1,DLL3, DLL4, Jagged-1 and Jagged-2) <ref type="bibr" target="#b33">[34]</ref>.</s><s>Amongst these molecules, Notch2 is associated with proliferation, invasion and metastasis in numerous tumour types, such as gastric carcinoma <ref type="bibr" target="#b23">[24,</ref><ref type="bibr" target="#b34">35]</ref>, laryngeal squamous cell carcinoma <ref type="bibr" target="#b35">[36]</ref> and salivary adenoid cystic carcinoma <ref type="bibr" target="#b36">[37]</ref>.</s><s>In the present study, we elucidated the molecular mechanism by which miR-184 inhibits NPC cell invasion and metastasis by directly targeting Notch2.</s><s>To achieve this goal, we examined the effect of Notch2 on the EMT process by wound-healing assay, Transwell assay and Western blot.</s><s>Notch2 knockdown decreased EMT progression and CNE-1 and CNE-2 cell invasion.</s><s>Notably, the inhibitory effects of miR-184 on EMT progression and cell invasion were partially abrogated by Notch2 knockdown in NPC cells.</s><s>Thus, these data clearly demonstrated that miR-184 inhibited NPC invasion and metastasis by repressing EMT progression through Notch2 suppression.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Conclusion</head><p><s>Our results demonstrated that miR-184 expression was downregulated in NPC cell lines.</s><s>MiR-184 also evidently suppressed NPC invasion and metastasis in vitro and in vivo.</s><s>Mechanistically, miR-184 inhibited the EMT progression of NPC by repressing Notch2.</s><s>Collectively, we believe that miR-184 plays an essential role in NPC progression and may serve as a promising therapeutic target for NPC treatment in the future.</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>Fig. 1 .</head><label>1</label><figDesc><div><p><s>Fig. 1.</s><s>MiR-184 was downregulated and Notch2 was upregulated in nasopharyngeal carcinoma cell lines.</s><s>(A) Expression levels of miR-184 in six NPC cell lines and NP69 cells through qRT-PCR.</s><s>N=3 for each group.</s><s>(B) Expression levels of Notch2 in six NPC cell lines and NP69 cells through qRT-PCR.</s><s>N=3 for each group.</s><s>(C) Western blot analysis for Notch2 expression in six NPC cell lines and NP69 cells.</s><s>β-actin antibody was used as the loading control.</s></p></div></figDesc><graphic coords="5,267.05,91.45,242.63,136.32" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>Fig. 1</head><label>1</label><figDesc><div><p><s>Fig.1 MiR-184 was downregulated and Notch2 was upregulated in nasopharyngeal carcinoma cell lines.</s><s>(A) Expression levels of miR-184 in six NPC cell lines and NP69 cells through qRT-PCR.</s><s>N=3 for each group.</s><s>(B) Expression levels of Notch2 in six NPC cell lines and NP69 cells through qRT-PCR.</s><s>N=3 for each group.</s><s>(C) Western blot analysis for Notch2 expression in six NPC cell lines and NP69 cells.</s><s>β-actin antibody was used as the loading control.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><head>Fig. 2 .</head><label>2</label><figDesc><div><p><s>Fig. 2. Overexpression of MiR-184 decreases invasion and migration in CNE-1 and CNE-2 cell lines.</s><s>(A) The relative expression levels of miR-184 after transfection.</s><s>(B) The effects of miR-184 mimics on migration ability of NPC.</s><s>(C) The invasion capacity of cells was investigated using a Matrigel invasion assay.</s><s>(D) The migration of cells was examined using a wound healing assay.</s><s>Results are presented as the mean±standard deviation (n=3).</s><s>*P&lt;0.05;</s><s>**P&lt;0.01;</s><s>***P&lt;0.001.</s></p></div></figDesc><graphic coords="5,262.67,234.57,241.88,408.14" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_3"><head>©</head><label></label><figDesc><div><p><s>2018 The Author(s).</s><s>Published by S. Karger AG, Basel www.karger.com/cpb</s><s>Zhu et al.: miR-184 Inhibits Tumor Invasion</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_4"><head>Fig. 4 .</head><label>4</label><figDesc><div><p><s>Fig. 4. miR-184 mimics and inhibitor led to the changes of EMT markers'expression.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_5"><head>Fig4</head><label></label><figDesc><div><p><s>Fig4. miR-184 mimics and inhibitor led to the changes of EMT markers ' expression.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_6"><head>Fig. 3 .</head><label>3</label><figDesc><div><p><s>Fig. 3. Inhibition of MiR-184 increases invasion and migration in CNE-1 and CNE-2 cell lines.</s><s>(A) The effects of miR-184 inhibitor on migration ability of NPC.</s><s>(B) The invasion capacity of cells was investigated using a Matrigel invasion assay.</s><s>(C) The migration of cells was examined using a wound healing assay.</s><s>Results are presented as the mean±standard deviation (n=3).</s><s>**P&lt;0.01;</s><s>***P&lt;0.001.</s></p></div></figDesc><graphic coords="6,261.64,499.13,239.28,143.55" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_7"><head>Fig3.</head><label></label><figDesc><div><p><s>Fig3.</s><s>Inhibition of MiR-184 increases invasion and migration in CNE-1 and CNE-2 cell lines.</s><s>(A)The effects of miR-184 inhibitor on migration ability of NPC.(B)The invasion capacity of cells was investigated using a Matrigel invasion assay.</s></p></div></figDesc><graphic coords="6,257.44,87.66,245.24,326.75" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_8"><head>Fig. 5 .</head><label>5</label><figDesc><div><p><s>Fig. 5.</s><s>The prediction and validation of miR-184 target gene.</s><s>(A)The prediction and validation of miR-184 target gene.</s><s>(B) Luciferase assays validated that Notch2 is a target of miR-184.</s><s>(C,D and E) Further evidence of miR-184 targeting Notch2 by qRT-PCR, and western blotting.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_9"><head>Fig5.</head><label></label><figDesc><div><p><s>Fig5.</s><s>The prediction and validation of miR-184 target gene.</s><s>(A)The prediction and validation of miR-184 target gene.</s><s>(B) Luciferase assays validated that Notch2 is a target of miR-184.</s><s>(C,D and E) Further evidence of miR-184 targeting Notch2 by qRT-PCR, and western blotting.</s></p></div></figDesc><graphic coords="7,210.89,84.36,293.11,221.53" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_10"><head>Fig. 6 .</head><label>6</label><figDesc><div><p><s>Fig. 6.</s><s>Notch2 promotes EMT of NPC.</s><s>(A) shRNA transfection of Notch2 could inhibit its expression.</s><s>(B, D) shRNA-Notch2 inhibited migration ability of NPC.</s><s>(C) shRNA-Notch2 inhibited invasion ability of NPC.</s><s>(E) shRNA-Notch2 regulated EMT markers of NPC.</s><s>**P&lt;0.01;</s><s>***P&lt;0.001.</s></p></div></figDesc><graphic coords="8,221.36,88.32,278.71,499.28" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_11"><head>Fig. 7 .</head><label>7</label><figDesc><div><p><s>Fig. 7.</s><s>The miR-184-mediated EMT process depends on Notch2.</s><s>(A, B) miR-184 inhibitor caused an increase in NPC cells'migration and invasive ability, whereas shRNA-Notch2 could abolish this change.</s><s>(C) miR-184 inhibitor led to increase of N-cadherin and Vimentin and decrease of E-cadherin, whereas co-transfection with shRNA-Notch2 partially abolished these changes.</s><s>*P&lt;0.05;</s><s>**P&lt;0.01.</s></p></div></figDesc><graphic coords="9,177.99,82.47,325.48,482.48" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_12"><head>Fig7.</head><label></label><figDesc><div><p><s>Fig7.</s><s>The miR-184-mediated EMT process depends on Notch2.</s><s>(A, B) miR-184</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_13"><head>Fig. 8 .</head><label>8</label><figDesc><div><p><s>Fig. 8. miR-184 inhibited NPC metastasis via decrease EMT in vivo.</s><s>(A,B) Photographs of mice injected with agomir-NC or agomir-184, antagomir-NC or antagomir-184, negative control.The metastasis nodules are indicated by arrows.</s><s>(C) Tumor weight averages between negative control, agomir-NC, agomir-184, antagomir-NC and antagomir-184 mice groups at the end of the experiment (day 41).</s><s>(D) Graph representing tumor volumes averages between negative control, agomir-NC, agomir-184, antagomir-NC and antagomir-184 mice groups at the end of the experiment (day 41).</s><s>five mice in each group.</s><s>(E) The graph gives the incidences of metastasis in mice that had received footpad injections of each cell line.</s><s>*P&lt;0.05;</s><s>**P&lt;0.01,***P&lt;0.001.</s></p></div></figDesc><graphic coords="10,222.49,85.82,282.67,349.66" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_14"><head>Fig8</head><label></label><figDesc><div><p><s>Fig8. miR-184 inhibited NPC metastasis via decrease EMT in vivo.(A,B)</s><s>Photographs of mice injected with agomir-NC or agomir-184, antagomir-NC or antagomir-184, negative control.The metastasis nodules are indicated by arrows.</s><s>(C)Tumor weight averages between negative control, agomir-NC, agomir-184, antagomir-NC and antagomir-184 mice groups at the end of the experiment (day 41).</s><s>(D) Graph representing tumor volumes averages between negative control,</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_15"><head>Fig. 9 .</head><label>9</label><figDesc><div><p><s>Fig. 9. (A) HE staining result of the tumor formed in nude mice using, paraffinembedded tumor sections were stained with antivimentin, E-cadherin and N-cadherin.</s><s>Representative figures were shown.</s><s>(B,C and D) Primary tumor E-cadherin, N-cadherin, Vimentin expression levels in HE staining.</s><s>(E) In agomir-184 group, primary tumor and metastasis tumor E-cadherin, N-cadherin, Vimentin expression levels in HE staining.</s><s>*P&lt;0.05;</s><s>**P&lt;0.01;</s><s>***P&lt;0.001.</s></p></div></figDesc><graphic coords="11,218.27,80.37,284.11,519.85" type="bitmap" /></figure>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">DOI: 10.1159/000493458 Published online: 13 September, 2018</note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">© 2018 The Author(s). Published by S. Karger AG, Basel www.karger.com/cpb</note>
		</body>
		<back>

			<div type="acknowledgement">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Acknowledgements</head><p><s>We thank the members of the Research Center of Clinical Oncology of of Jiangsu province for their technical assistance.</s><s>This study was supported by the National Natural Science Foundation of China (81672989), the Jiangsu Provincial Commission of Health and Family Planning Youth Fund (Q201501), the JiangSu Clinical Medicine Science and Technology Special Fund (No. BL2014091), the Young Medical Talent Fund of JiangSu Provincial Department for Health (QNRC2016648).</s></p></div>
			</div>

			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Disclosure Statement</head><p><s>The authors declare that they have no competing interests.</s></p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">XH: miR-99a suppresses cell invasion and metastasis in nasopharyngeal carcinoma through targeting HOXA1</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">G</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">P</forename><surname>Tang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Liao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">P</forename><surname>Liu</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Onco Targets Ther</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page" from="753" to="761" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">MiR-223 targeting MAFB suppresses proliferation and migration of nasopharyngeal carcinoma cells</title>
		<author>
			<persName><forename type="first">W</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Lan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Lu</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">BMC Cancer</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="page">461</biblScope>
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">MicroRNA-212 inhibits the metastasis of nasopharyngeal carcinoma by targeting SOX4</title>
		<author>
			<persName><forename type="first">C</forename><surname>Jiang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Zhou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Jiang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Xu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Xia</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Oncol Rep</title>
		<imprint>
			<biblScope unit="volume">38</biblScope>
			<biblScope unit="page" from="82" to="88" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Implications of MicroRNAs in the Treatment of Gefitinib-Resistant Non-Small Cell Lung Cancer</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">K</forename><surname>Sin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Meng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">C</forename><surname>Wong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">C</forename><surname>Cho</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">M</forename><surname>Siu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">W</forename><surname>Chan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Yung</forename><surname>By</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Int J Mol Sci</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="page">237</biblScope>
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Regulation of cancer metastasis by cell-free miRNAs</title>
		<author>
			<persName><forename type="first">M</forename><surname>Aleckovic</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Kang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biochim Biophys Acta</title>
		<imprint>
			<biblScope unit="volume">1855</biblScope>
			<biblScope unit="page" from="24" to="42" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">The role of microRNAs in nasopharyngeal carcinoma</title>
		<author>
			<persName><forename type="first">G</forename><surname>Tan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Tang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Tang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Tumour Biol</title>
		<imprint>
			<biblScope unit="volume">36</biblScope>
			<biblScope unit="page" from="69" to="79" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">MiR-205 promotes proliferation, migration and invasion of nasopharyngeal carcinoma cells by activation of AKT signalling</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Mao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Wu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Zhao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Q</forename><surname>Deng</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Int Med Res</title>
		<imprint>
			<biblScope unit="volume">44</biblScope>
			<biblScope unit="page" from="231" to="240" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">MiR-145 inhibits metastasis by targeting fascin actin-bundling protein 1 in nasopharyngeal carcinoma</title>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">Q</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Q</forename><forename type="middle">M</forename><surname>He</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><forename type="middle">Y</forename><surname>Ren</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><forename type="middle">R</forename><surname>Tang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">F</forename><surname>Xu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Wen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><forename type="middle">J</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Ma</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Liu</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">PLoS One</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page">e0122228</biblScope>
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">Downregulation of miR429 and inhibition of cell migration and invasion in nasopharyngeal carcinoma</title>
		<author>
			<persName><forename type="first">F</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Jiang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Q</forename><surname>Sun</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Yan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Fu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Hu</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mol Med Rep</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="page" from="3236" to="3242" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">Functions of microRNA-143 in the apoptosis, invasion and migration of nasopharyngeal carcinoma</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">H</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">P</forename><surname>Wang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Exp Ther Med</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="page" from="3749" to="3755" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">MicroRNA-148b suppresses proliferation, migration, and invasion of nasopharyngeal carcinoma cells by targeting metastasis-associated gene 2</title>
		<author>
			<persName><forename type="first">M</forename><surname>Wu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Ye</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Q</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Lai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Yi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Onco Targets Ther</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page" from="2815" to="2822" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">MicroRNA-184 promotes differentiation of the retinal pigment epithelium by targeting the AKT2/mTOR signaling pathway</title>
		<author>
			<persName><forename type="first">C</forename><surname>Jiang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Qin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Sun</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Shi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Ding</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Zhu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Zhao</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Oncotarget</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="page" from="52340" to="52353" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">Characteristic MicroRNA Expression Induced by delta-Opioid Receptor Activation in the Rat Liver Under Prolonged Hypoxia</title>
		<author>
			<persName><forename type="first">F</forename><surname>Zhi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Shao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Xue</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Xu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Kang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Xia</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cell Physiol Biochem</title>
		<imprint>
			<biblScope unit="volume">44</biblScope>
			<biblScope unit="page" from="2296" to="2309" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">Suppression of miR-184 in malignant gliomas upregulates SND1 and promotes tumor aggressiveness</title>
		<author>
			<persName><forename type="first">L</forename><surname>Emdad</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Janjic</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Alzubi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Hu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">K</forename><surname>Santhekadur</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">E</forename><surname>Menezes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><forename type="middle">N</forename><surname>Shen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">K</forename><surname>Das</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Sarkar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">B</forename><surname>Fisher</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neuro Oncol</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="page" from="419" to="429" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">MicroRNA-184 inhibits cell proliferation and invasion, and specifically targets TNFAIP2 in Glioma</title>
		<author>
			<persName><forename type="first">Z</forename><surname>Cheng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">Z</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Wu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Han</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Xie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Huang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Du</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Zhou</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Exp Clin Cancer Res</title>
		<imprint>
			<biblScope unit="volume">34</biblScope>
			<biblScope unit="page">27</biblScope>
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">MicroRNA-184 Modulates Human Central Nervous System Lymphoma Cells Growth and Invasion by Targeting iASPP</title>
		<author>
			<persName><forename type="first">X</forename><forename type="middle">G</forename><surname>Liang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">T</forename><surname>Meng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">J</forename><surname>Hu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Xing</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Xie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">Q</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">Q</forename><surname>Jia</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Cell Biochem</title>
		<imprint>
			<biblScope unit="volume">118</biblScope>
			<biblScope unit="page" from="2645" to="2653" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">microRNA-184 functions as tumor suppressor in renal cell carcinoma</title>
		<author>
			<persName><forename type="first">Z</forename><surname>Su</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Yu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Jiang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Ni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Gui</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Exp Ther Med</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page" from="961" to="966" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">Expression and functional perspectives of miR-184 in pancreatic ductal adenocarcinoma</title>
		<author>
			<persName><forename type="first">H</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Xiang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Ge</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Xiong</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Int J Clin Exp Pathol</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page" from="12313" to="12318" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Mir-184 post-transcriptionally regulates SOX7 expression and promotes cell proliferation in human hepatocellular carcinoma</title>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">G</forename><surname>Wu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">H</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">G</forename><surname>He</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Jiang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">X</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">F</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Q</forename><forename type="middle">L</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">N</forename><surname>Huang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><forename type="middle">C</forename><surname>Zeng</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">PLoS One</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page">e88796</biblScope>
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">Mature miR-184 as Potential Oncogenic microRNA of Squamous Cell Carcinoma of Tongue</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">S</forename><surname>Wong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><forename type="middle">B</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">Y</forename><surname>Wong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">W</forename><surname>Ng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">P</forename><surname>Yuen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">I</forename><surname>Wei</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Cancer Res</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="page" from="2588" to="2592" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">Fang W: Tumor suppressor PDCD4 modulates miR-184-mediated direct suppression of C-MYC and BCL2 blocking cell growth and survival in nasopharyngeal carcinoma</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Zhen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Yu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Q</forename><surname>Wu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Hua</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Long</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Q</forename><surname>Jiang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Song</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Cheng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Zhao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Q</forename><surname>Fu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Lyu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Fan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Li</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cell Death Dis</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="page">e872</biblScope>
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">MiR-145, a microRNA targeting ADAM17, inhibits the invasion and migration of nasopharyngeal carcinoma cells</title>
		<author>
			<persName><forename type="first">J</forename><surname>Wu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Yin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Jiang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">J</forename><surname>Guo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">J</forename><surname>Gu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">Y</forename><surname>Xia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">Z</forename><surname>Wu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">F</forename><surname>Wu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">J</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Zong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Ding</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Huang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>He</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Exp Cell Res</title>
		<imprint>
			<biblScope unit="volume">338</biblScope>
			<biblScope unit="page" from="232" to="238" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">Cancer metastasis directly eradicated by targeted therapy with a modified Salmonella typhimurium</title>
		<author>
			<persName><forename type="first">K</forename><surname>Hayashi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Zhao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Yamauchi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Yamamoto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Tsuchiya</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Tomita</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">M</forename><surname>Hoffman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Cell Biochem</title>
		<imprint>
			<biblScope unit="volume">106</biblScope>
			<biblScope unit="page" from="992" to="998" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">MicroRNA-107 inhibits glioma cell migration and invasion by modulating Notch2 expression</title>
		<author>
			<persName><forename type="first">L</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><forename type="middle">R</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Yan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><forename type="middle">D</forename><surname>Jiang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Neurooncol</title>
		<imprint>
			<biblScope unit="volume">112</biblScope>
			<biblScope unit="page" from="59" to="66" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">miR-146a-5p mediates epithelial-mesenchymal transition of oesophageal squamous cell carcinoma via targeting Notch2</title>
		<author>
			<persName><forename type="first">C</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Guan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Sun</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Un</forename><surname>Nesa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Cheng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Yousef</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">M</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Br J Cancer</title>
		<imprint>
			<biblScope unit="volume">115</biblScope>
			<biblScope unit="page" from="1548" to="1554" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">MicroRNA-184 inhibits cell proliferation and metastasis in human colorectal cancer by directly targeting IGF-1R</title>
		<author>
			<persName><forename type="first">G</forename><surname>Wu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Wu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Wu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Yao</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Oncol Lett</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="page" from="3215" to="3222" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">miR-184 functions as an oncogenic regulator in hepatocellular carcinoma (HCC)</title>
		<author>
			<persName><forename type="first">B</forename><surname>Gao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Gao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Huang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Lin</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biomed Pharmacother</title>
		<imprint>
			<biblScope unit="volume">68</biblScope>
			<biblScope unit="page" from="143" to="148" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">Epithelial-mesenchymal transition in tumor metastasis</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">T</forename><surname>Yeung</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Yang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mol Oncol</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page" from="28" to="39" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">The role of Notch signaling pathway in epithelial-mesenchymal transition (EMT) during development and tumor aggressiveness</title>
		<author>
			<persName><forename type="first">Z</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Kong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">H</forename><surname>Sarkar</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Curr Drug Targets</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page" from="745" to="751" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">Notch1 signaling regulates the epithelial-mesenchymal transition and invasion of breast cancer in a Slug-dependent manner</title>
		<author>
			<persName><forename type="first">S</forename><surname>Shao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Zhao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Luo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Zuo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Huang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Gu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Zhao</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mol Cancer</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="page">28</biblScope>
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main">Notch signaling induces epithelial-mesenchymal transition to promote invasion and metastasis in adenoid cystic carcinoma</title>
		<author>
			<persName><forename type="first">Z</forename><forename type="middle">L</forename><surname>Zhao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">R</forename><surname>Ma</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">M</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">F</forename><surname>Huang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">T</forename><surname>Yu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">F</forename><surname>Wu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">L</forename><surname>Bu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">F</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">F</forename><surname>Zhao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">F</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><forename type="middle">J</forename><surname>Sun</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Transl Res</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="page" from="162" to="174" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main">Activation of Notch pathway is linked with epithelialmesenchymal transition in prostate cancer cells</title>
		<author>
			<persName><forename type="first">L</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Sha</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Huang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Bo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Huang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cell Cycle</title>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="page" from="999" to="1007" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main">Notch signaling is important for epithelial-mesenchymal transition induced by low concentrations of doxorubicin in osteosarcoma cell lines</title>
		<author>
			<persName><forename type="first">J</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Guo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Yu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Mei</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Fang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Xia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Liu</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Oncol Lett</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="page" from="2260" to="2268" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main">Notch signaling: targeting cancer stem cells and epithelial-to-mesenchymal transition</title>
		<author>
			<persName><forename type="first">I</forename><surname>Espinoza</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Pochampally</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Xing</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Watabe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Miele</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Onco Targets Ther</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="page" from="1249" to="1259" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main">Notch2-induced COX-2 expression enhancing gastric cancer progression</title>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">C</forename><surname>Tseng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">H</forename><surname>Tsai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Tseng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">W</forename><surname>Hsu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">H</forename><surname>Huang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">F</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">W</forename><surname>Chi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">H</forename><surname>Hsieh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">H</forename><surname>Ku</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">S</forename><surname>Yeh</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mol Carcinog</title>
		<imprint>
			<biblScope unit="volume">51</biblScope>
			<biblScope unit="page" from="939" to="951" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main">Notch 2 signaling contributes to cell growth, anti-apoptosis and metastasis in laryngeal squamous cell carcinoma</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Zou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Fang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">J</forename><surname>Ding</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">Y</forename><surname>Dai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Yi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><forename type="middle">Z</forename><surname>Tao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Chen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mol Med Rep</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="page" from="3517" to="3524" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main">Notch2 signaling contributes to cell growth, invasion, and migration in salivary adenoid cystic carcinoma</title>
		<author>
			<persName><forename type="first">J</forename><surname>Qu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Song</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Xie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><forename type="middle">Y</forename><surname>Huang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><forename type="middle">M</forename><surname>Hu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">H</forename><surname>Gan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Zhao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">S</forename><surname>Lin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Lin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">L</forename><surname>Zheng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">G</forename><surname>Lu</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mol Cell Biochem</title>
		<imprint>
			<biblScope unit="volume">411</biblScope>
			<biblScope unit="page" from="135" to="141" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
